Genmab A/S (GMAB.CO)

Copenhagen · Healthcare · Biotechnology
3,469.00 DKK-0.80%As of 2026-11-22 · DKK
Last session low 3,465.00 DKKLast session high 3,515.00 DKK
52-week low 1,512.00 DKK52-week high 3,947.00 DKK
Market cap (USD)
$31.39B
Sector
Healthcare
P/E (TTM)
46.1x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in DKK.

IndicatorValueReading
RSI (14)61.1In the neutral range (30 to 70)
MACD (12, 26, 9)188.16Below its signal line (242.64); histogram -54.48
Bollinger %B (20, 2)41%Inside the bands (3,095.69 to 4,004.11)
SMA 203,549.90Price is 2.3% below
SMA 502,851.30Price is 21.7% above
SMA 2002,084.30Price is 66.4% above
ATR (20)3.96% of priceAverage true range per day
52-week position80%In the upper part of the 1,512.00 to 3,947.00 range

About Genmab A/S

Genmab A/S, a biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

Latest fiscal yearEnded 2025-12-31: revenue of $3.72B and an operating margin of 33.6%.

Also listed as GMAB (NasdaqGS)

More in Biotechnology